Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Impact of Body Weight on Mortality After Stroke

The Impact of Body Weight on Mortality After Stroke Letters 3. Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt reliosis from subjective neurocognitive symptoms thought po- KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245(5):262-272. tentially attributable to B burgdorferi infection. However, a 4. Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in number of other conditions, including tick-borne encephali- Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013;13:2. tis and neurosyphilis, are associated with elevated CSF CXCL13 5. Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J. CXCL13 and 3,6 levels. At present, CSF CXCL13 levels do not adequately dis- neopterin concentrations in cerebrospinal fluid of patients with Lyme criminate neuroborreliosis from other neuroinflammatory con- neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation. 2014;11:103. ditions to justify diagnostic CSF testing for assessment of this parameter alone. In Reply We agree with Lautner and colleagues that, in addi- tion to the ratio of Borrelia burgdorferi antibodies between ce- Michael T. Melia, MD rebrospinal fluid (CSF) and serum, tests, such as CSF white Paul M. Lantos, MD blood cell count, can be useful in the assessment of neurobor- Paul G. Auwaerter, MD reliosis. Indeed, CSF analysis is a pivotal http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

The Impact of Body Weight on Mortality After Stroke

JAMA Neurology , Volume 72 (1) – Jan 1, 2015

Loading next page...
 
/lp/american-medical-association/the-impact-of-body-weight-on-mortality-after-stroke-PV1TpzptKQ
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2014.3631
pmid
25581865
Publisher site
See Article on Publisher Site

Abstract

Letters 3. Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt reliosis from subjective neurocognitive symptoms thought po- KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245(5):262-272. tentially attributable to B burgdorferi infection. However, a 4. Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in number of other conditions, including tick-borne encephali- Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013;13:2. tis and neurosyphilis, are associated with elevated CSF CXCL13 5. Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J. CXCL13 and 3,6 levels. At present, CSF CXCL13 levels do not adequately dis- neopterin concentrations in cerebrospinal fluid of patients with Lyme criminate neuroborreliosis from other neuroinflammatory con- neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation. 2014;11:103. ditions to justify diagnostic CSF testing for assessment of this parameter alone. In Reply We agree with Lautner and colleagues that, in addi- tion to the ratio of Borrelia burgdorferi antibodies between ce- Michael T. Melia, MD rebrospinal fluid (CSF) and serum, tests, such as CSF white Paul M. Lantos, MD blood cell count, can be useful in the assessment of neurobor- Paul G. Auwaerter, MD reliosis. Indeed, CSF analysis is a pivotal

Journal

JAMA NeurologyAmerican Medical Association

Published: Jan 1, 2015

References